115 related articles for article (PubMed ID: 4442341)
1. [Metabolism of the antineoplastic agent N-pyrimidly-2N1, N2-di-(ethylene)-triamide phosphate (fosfemid)].
Safonova TS; Linberg LF; Presnova ZhF; Kuriatov NS; Chernov VA
Dokl Akad Nauk SSSR; 1974; 219(5):1271-2. PubMed ID: 4442341
[No Abstract] [Full Text] [Related]
2. [Study of the pharmacokinetics of phosphemide in rats with the use of physico-chemical methods].
Safonova TS; Presnova ZhF; Linberg LF; Chernov VA; Kuriatov NS
Farmakol Toksikol; 1975; 38(4):491-4. PubMed ID: 1213145
[TBL] [Abstract][Full Text] [Related]
3. The metabolism of the anti-tumour agent 1(1-aziridinyl)- 2,4-dinitrobenzene (CB 1837).
Connors TA; Hickman JA; Jarman M; Melzack DH; Ross WC
Biochem Pharmacol; 1975 Sep; 24(18):1665-70. PubMed ID: 1191326
[No Abstract] [Full Text] [Related]
4. The metabolism of the anti-tumour agent 5-(1-aziridinyl)-2,4-dinitrobenzamide (CB 1954).
Jarman M; Melzack DH; Ross WC
Biochem Pharmacol; 1976 Nov; 25(22):2475-8. PubMed ID: 985569
[No Abstract] [Full Text] [Related]
5. [Kinetics of accumulation and elimination of 14C-dipine, an antineoplastic drug].
Korolev GK; Kurasova VG; Kurchatova VV
Farmakol Toksikol; 1978; 41(4):473-80. PubMed ID: 668875
[TBL] [Abstract][Full Text] [Related]
6. Structure activity relationships in a series of anti-neoplastic dinitrophenyl aziridines--protein binding studies.
Hickman JA
Biochem Pharmacol; 1974 Oct; 23(20):2833-8. PubMed ID: 4473986
[No Abstract] [Full Text] [Related]
7. Metabolism of iphosphamide (2-(2-chloroethylamino)-3-(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide) and production of a toxic iphosphamide metabolite.
Hill DL; Laster WR; Kirk MC; el-Dareer S; Struck RF
Cancer Res; 1973 May; 33(5):1016-22. PubMed ID: 4703116
[No Abstract] [Full Text] [Related]
8. [Pharmacokinetics of P32-phosphemide in the body of rats with sarcoma 45].
Filatov PP; Vatin AE; Averina SA; Savin IuI
Farmakol Toksikol; 1976; 39(5):598-600. PubMed ID: 1028587
[TBL] [Abstract][Full Text] [Related]
9. Biochemical activation of AZQ [3,6-diaziridinyl-2,5-bis(carboethoxyamino)-1,4-benzoquinone] to its free radical species.
Gutierrez PL; Friedman RD; Bachur NR
Cancer Treat Rep; 1982 Feb; 66(2):339-42. PubMed ID: 6275990
[TBL] [Abstract][Full Text] [Related]
10. Mechanism(s) of bioreductive activation. The example of diaziquone (AZQ).
Gutierrez PL
Free Radic Biol Med; 1989; 6(4):405-45. PubMed ID: 2651223
[TBL] [Abstract][Full Text] [Related]
11. Effects of ascorbic acid on biologically obtained diaziquone free radicals.
Gutierrez PL; Egorin MJ; Davis TA; Bachur NR
Biochem Pharmacol; 1985 Jul; 34(13):2394-7. PubMed ID: 2990485
[No Abstract] [Full Text] [Related]
12. A new metabolic reaction of diaziridines by rat liver microsomes.
Hata Y; Watanabe M
Biochem Biophys Res Commun; 1982 May; 106(2):526-32. PubMed ID: 7104007
[No Abstract] [Full Text] [Related]
13. The murine disposition and pharmacokinetics of the antineoplastic agent, diaziquone (NSC 182986).
Spiegel JF; Egorin MJ; Collins JM; Lerner BD; Bachur NR
Drug Metab Dispos; 1983; 11(1):41-6. PubMed ID: 6132794
[TBL] [Abstract][Full Text] [Related]
14. [Effect of phosphemide in combination with dexamethasone on DNA structure in sarcoma 45].
Babaian IuS; Aslanian LL; Ananian GV; Garibian DV
Biofizika; 1985; 30(3):414-7. PubMed ID: 4027269
[TBL] [Abstract][Full Text] [Related]
15. [Study of the decomposition of alkylating mutagens of the ethyleneimine series in human lymphocyte cultures].
Kirichenko OP; Chebotarev AN; Lakovenko KN
Biull Eksp Biol Med; 1976 May; 81(5):552-3. PubMed ID: 820384
[TBL] [Abstract][Full Text] [Related]
16. [Use of Bacillus megaterium H. in studying the antitumor properties of new ethyleneimine derivatives of N-dichlorophosphonyliminotri-chloroacetic acid trichlorophosphopolyalkane halides and chloroanhydridies].
Kutovoĭ AI; Siadro TA; Petrenko VS; Solodushchenko GF; Teliuk VG
Mikrobiol Zh; 1978; 40(5):633-6. PubMed ID: 723679
[No Abstract] [Full Text] [Related]
17. Absorption, tissue distribution, and excretion of the anti-neoplastic agent guanazole in the rat.
Musa MN; Lower GM; Welling PG; Johnson BM; Kaiman BD; Bryan GT
Res Commun Chem Pathol Pharmacol; 1974 Mar; 7(3):497-512. PubMed ID: 4824824
[No Abstract] [Full Text] [Related]
18. Cytotoxic activity and fragmentation of aziridines in microsomes.
Hata Y; Watanabe M; Shiratori O; Takase S
Biochem Biophys Res Commun; 1978 Feb; 80(4):911-6. PubMed ID: 637875
[No Abstract] [Full Text] [Related]
19. [Effect of phosphemide on the glycogen content in the organs of white rats].
Zykov AA; Malakhova RG; Malykh EA; Churkina MG
Farmakol Toksikol; 1979; 42(3):283-4. PubMed ID: 446712
[TBL] [Abstract][Full Text] [Related]
20. Enzyme-induced aziridine formation by rat liver microsomes.
Hata Y; Watanabe M
Biochem Biophys Res Commun; 1983 Jan; 110(1):220-7. PubMed ID: 6838512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
